Centerview HC group falling off?
Just a few years ago, CVP's biopharma group was on nearly 85% of sell-side mandates, and this year they seemed to have missed out on several multi billion dollar deals (ex: vertex/crinetics, abbvie/apogee, biogen/apellis, etc.)
Is CVP declining while firms like Leerink and Jefferies are gaining ground in this space?
What are you talking about. Leerink and LAZ are even behind JEF healthcare, let alone CVP
sorry meant to say JEF instead of laz but you get the point, Leerink is doing great this year btw on the M&A side
I agree that CVP was no longer the “only player” in the biotech game anymore, but they still executed most deals this year
Leerink picking up but absolute worst place to work and no future for the firm
Leerink sleeper agent
Oh wow
Leerink could possibly reach CVP levels within the next 5 years with their new MDs
Voluptatem quaerat quod commodi blanditiis enim atque. Eos voluptate sunt ratione dignissimos modi sunt. Velit vel voluptates facilis vel sunt est aliquid ad.
Quas ad dolor hic quis quas sunt molestiae. Optio voluptatum quos aliquid eum reiciendis velit.
Sit cumque et nam at et ea. Cumque est quod tenetur. A minima ut repudiandae dolorem et fuga. Inventore molestiae pariatur nulla nulla cumque. Non sit quidem nisi ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...